Gregory P Chang

This inventor holds 12 USPTO granted patents and 43 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Dragonfly Therapeutics, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 12 (Patent Applications = 43)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 39)

EPO Patents = 4 (Patent Applications = 41)

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

12 out of 14

Dragonfly Therapeutics, Inc.

patents

Years Active: 2023-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384851 - Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use (2025-08-12),

2. 12384847 - Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen (2025-08-12),

3. 12378318 - Proteins binding NKG2D, CD16 and a tumor-associated antigen (2025-08-05),

4. 12275791 - Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use (2025-04-14),

5. 12264200 - Antibody variable domains targeting the NKG2D receptor (2025-04-01),

6. 12215157 - Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use (2025-02-04),

7. 12157771 - Proteins binding NKG2D, CD16 and CLEC12A (2024-12-03),

8. 12129300 - Antibody variable domains targeting the NKG2D receptor (2024-10-29),

9. 11939384 - Antibody variable domains targeting the NKG2D receptor (2024-03-26),

10. 11884733 - Antibody variable domains targeting the NKG2D receptor (2024-01-30),

11. 11884732 - Proteins binding HER2, NKG2D and CD16 (2024-01-30),

12. 11834506 - Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer (2023-12-05),

Title: The Innovative Journey of Gregory P Chang

Introduction: Gregory P Chang, a talented inventor hailing from Medford, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Gregory P Chang's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, Gregory P Chang has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has garnered recognition from industry experts and peers alike.

Collaborations: Throughout his career, Gregory P Chang has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Gregory P Chang's passion for innovation and commitment to pushing the boundaries of technology continue to drive his success in the field of invention. His relentless pursuit of excellence serves as an inspiration to aspiring inventors around the world.